Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Yancopoulos George
Relationship:   Bd. Co-Chair, Presiden...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   868,994    

Indirect Shares

   241,951      
Direct Value   $900,729,661    

Indirect Value

   $250,787,051      
Total Shares   1,110,945      
Total Value   $1,151,516,711      


Regeneron Pharmaceuticals Inc $900,729,661 Regeneron Pharmaceuticals Inc $900,729,661
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Regeneron Pharmaceuticals Inc REGN Bd. Co-Chair, Presiden... 2024-06-10 868,994 2024-06-10 241,951    Premium*  
* Premium Members only  

Records found :    147         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
REGN Regeneron Pharmaceuticals... EVP, CSO, & Pres Regn Res Labs   •       •      –    2008-12-16 4 OE $7.41 $741,000 D/D 100,000 636,103 0 -
REGN Regeneron Pharmaceuticals... EVP, CSO, & Pres Regn Res Labs   •       •      –    2008-12-16 4 AS $16.40 $442,652 D/D (26,991) 563,094 0 -
REGN Regeneron Pharmaceuticals... EVP CSO & Pres Regn Res Labs   •       •      –    2009-12-03 4 D $19.29 $1,309,019 D/D (67,860) 620,375 0 -
REGN Regeneron Pharmaceuticals... EVP CSO & Pres Regn Res Labs   •       •      –    2009-12-03 4 OE $8.77 $877,000 D/D 100,000 688,235 0 -
REGN Regeneron Pharmaceuticals... EVP CSO & Pres Regn Res Labs   •       •      –    2010-12-14 4/A A $0.00 $0 D/D 250,000 870,375 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2011-11-30 4 D $58.19 $8,304,993 D/D (142,722) 926,983 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2011-11-30 4 OE $28.01 $5,602,000 D/D 200,000 928,701 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2011-12-01 4 AS $58.86 $1,645,591 D/D (27,713) 899,270 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2011-12-14 4 D $51.18 $1,971,249 D/D (38,516) 860,754 0 -
REGN Regeneron Pharmaceuticals... EVP, CSO & Pres, REGN Res Labs   •       •      –    2012-01-05 4 AS $58.00 $1,607,354 D/D (27,713) 833,041 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2012-02-15 4 D $109.29 $7,324,288 D/D (67,017) 899,356 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2012-02-15 4 OE $8.50 $1,133,322 D/D 133,332 901,079 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2012-03-26 4 AS $120.21 $3,985,850 D/D (33,150) 866,206 0 -
REGN Regeneron Pharmaceuticals... EVP CSO President Regeneron Re   •       •      –    2012-05-01 4 AS $133.95 $4,471,669 D/D (33,165) 833,041 0 -
REGN Regeneron Pharmaceuticals... EVP CSO Pres REGN Res Lab   •       •      –    2012-06-27 4 A $0.00 $0 D/D 500,000 1,333,041 0 -
REGN Regeneron Pharmaceuticals... EVP CSO Pres Regen Res Labs   •       •      –    2012-12-14 4 D $179.13 $6,876,980 D/D (38,391) 1,294,650 0 -
REGN Regeneron Pharmaceuticals... EVP CSO Pres Regen Res Labs   •       •      –    2012-12-17 4 D $179.13 $42,728,775 D/D (238,535) 1,066,484 0 -
REGN Regeneron Pharmaceuticals... EVP CSO Pres Regen Res Labs   •       •      –    2012-12-17 4 OE $109.29 $1,133,228 D/D 10,369 1,304,811 0 -
REGN Regeneron Pharmaceuticals... EVP CSO Pres Regen Res Labs   •       •      –    2012-12-19 4 OE $9.49 $699,978 D/D 50,846 1,117,330 0 -
REGN Regeneron Pharmaceuticals... President Regeneron Laboratori   •       •      –    2013-05-06 4 OE $13.00 $2,500,004 D/D 192,308 1,309,638 0 -
REGN Regeneron Pharmaceuticals... President Regeneron Laboratori   •       •      –    2013-05-06 4 D $260.44 $26,888,607 D/D (103,243) 1,206,395 0 -
REGN Regeneron Pharmaceuticals... President Regeneron Laboratori   •       •      –    2013-05-07 4 S $261.66 $26,263,581 D/D (100,000) 1,106,395 0 -
REGN Regeneron Pharmaceuticals... Pres Regeneron Labs   •       •      –    2013-12-12 4 D $273.06 $2,561,849 D/D (9,382) 1,106,612 0 -
REGN Regeneron Pharmaceuticals... Pres Regeneron Labs   •       •      –    2013-12-12 4 OE $260.44 $2,499,964 D/D 9,599 1,115,994 0 -
REGN Regeneron Pharmaceuticals... Pres Regeneron Labs   •       •      –    2013-12-16 4 D $272.73 $11,720,299 D/D (42,974) 1,063,638 0 -
  147  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us